XML 46 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2013
Fair Value Disclosures [Abstract]  
Summary of assets and liabilities recorded at fair value
(In millions)
As of
December 31,
2013
 
Quoted
Prices in
Active
Markets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
424.7

 
$

 
$
424.7

 
$

Marketable debt securities:
 
 
 
 
 
 
 
Corporate debt securities
439.8

 

 
439.8

 

Government securities
674.7

 

 
674.7

 

Mortgage and other asset backed securities
131.4

 

 
131.4

 

Marketable equity securities
11.2

 
11.2

 

 

Venture capital investments
21.9

 

 

 
21.9

Derivative contracts
3.8

 

 
3.8

 

Plan assets for deferred compensation
22.7

 

 
22.7

 

Total
$
1,730.2

 
$
11.2

 
$
1,697.1

 
$
21.9

Liabilities:
 
 
 
 
 
 
 
Derivative contracts
$
23.5

 
$

 
$
23.5

 
$

Contingent consideration obligations
280.9

 

 

 
280.9

Total
$
304.4

 
$

 
$
23.5

 
$
280.9

(In millions)
As of
December 31,
2012
 
Quoted
Prices
in Active
Markets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
439.4

 
$

 
$
439.4

 
$

Marketable debt securities:
 
 
 
 
 
 
 
Corporate debt securities
1,001.0

 

 
1,001.0

 

Government securities
1,657.8

 

 
1,657.8

 

Mortgage and other asset backed securities
512.9

 

 
512.9

 

Marketable equity securities
9.0

 
9.0

 

 

Venture capital investments
20.3

 

 

 
20.3

Derivative contracts
1.8

 

 
1.8

 

Plan assets for deferred compensation
14.3

 

 
14.3

 

Total
$
3,656.5

 
$
9.0

 
$
3,627.2

 
$
20.3

Liabilities:
 
 
 
 
 
 
 
Derivative contracts
$
14.4

 
$

 
$
14.4

 
$

Contingent consideration obligations
293.9

 

 

 
293.9

Total
$
308.3

 
$

 
$
14.4

 
$
293.9

Fair value of venture capital investments
 
As of December 31,
(In millions)
2013
 
2012
Fair value, beginning of year
$
20.3

 
$
23.5

Unrealized gains included in earnings
10.5

 
5.4

Unrealized losses included in earnings
(6.3
)
 
(9.2
)
Purchases
0.7

 
0.6

Settlements
(3.3
)
 

Fair value, end of year
$
21.9

 
$
20.3

Summary of fair and carrying value of debt instruments
 
As of December 31,
(In millions)
2013
 
2012
Notes payable to Fumedica
$
17.5

 
$
20.0

Credit Facility

 

6.0% Senior Notes due March 1, 2013

 
453.7

6.875% Senior Notes due March 1, 2018
647.9

 
681.6

Total
$
665.4

 
$
1,155.3

Fair value of contingent consideration obligations
 
As of December 31,
(In millions)
2013
 
2012
Fair value, beginning of year
$
293.9

 
$
151.0

Additions

 
122.2

Changes in fair value
(0.5
)
 
27.2

Payments
(12.5
)
 
(6.5
)
Fair value, end of year
$
280.9

 
$
293.9